Literature DB >> 27090790

Structural and Nonstructural Viral Proteins Are Targets of T-Helper Immune Response against Human Respiratory Syncytial Virus.

Elena Lorente1, Alejandro Barriga1, Eilon Barnea2, Carmen Mir1, John A Gebe3, Arie Admon2, Daniel López4.   

Abstract

Proper antiviral humoral and cellular immune responses require previous recognition of viral antigenic peptides that are bound to HLA class II molecules, which are exposed on the surface of antigen-presenting cells. The helper immune response is critical for the control and the clearance of human respiratory syncytial virus (HRSV) infection, a virus with severe health risk in infected pediatric, immunocompromised, and elderly populations. In this study, using a mass spectrometry analysis of complex HLA class II-bound peptide pools that were isolated from large amounts of HRSV-infected cells, 19 naturally processed HLA-DR ligands, most of them included in a complex nested set of peptides, were identified. Both the immunoprevalence and the immunodominance of the HLA class II response to HRSV were focused on one nonstructural (NS1) and two structural (matrix and mainly fusion) proteins of the infective virus. These findings have clear implications for analysis of the helper immune response as well as for antiviral vaccine design.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27090790      PMCID: PMC5083087          DOI: 10.1074/mcp.M115.057356

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  33 in total

1.  Unusual viral ligand with alternative interactions is presented by HLA-Cw4 in human respiratory syncytial virus-infected cells.

Authors:  Susana Infantes; Elena Lorente; Juan José Cragnolini; Manuel Ramos; Ruth García; Mercedes Jiménez; Salvador Iborra; Margarita Del Val; Daniel López
Journal:  Immunol Cell Biol       Date:  2010-10-26       Impact factor: 5.126

2.  The interactome of the human respiratory syncytial virus NS1 protein highlights multiple effects on host cell biology.

Authors:  Weining Wu; Kim C Tran; Michael N Teng; Kate J Heesom; David A Matthews; John N Barr; Julian A Hiscox
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

3.  Stable isotope tagging of epitopes: a highly selective strategy for the identification of major histocompatibility complex class I-associated peptides induced upon viral infection.

Authors:  Hugo D Meiring; Ernst C Soethout; Martien C M Poelen; Dennis Mooibroek; Ronald Hoogerbrugge; Hans Timmermans; Claire J Boog; Albert J R Heck; Ad P J M de Jong; Cécile A C M van Els
Journal:  Mol Cell Proteomics       Date:  2006-01-23       Impact factor: 5.911

4.  Two populations of Ia-like molecules on a human B cell line.

Authors:  L A Lampson; R Levy
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

Review 5.  Pathways of antigen processing.

Authors:  Janice S Blum; Pamela A Wearsch; Peter Cresswell
Journal:  Annu Rev Immunol       Date:  2013-01-03       Impact factor: 28.527

6.  Sendai virus gene expression in lytically and persistently infected cells.

Authors:  H E Homann; P H Hofschneider; W J Neubert
Journal:  Virology       Date:  1990-07       Impact factor: 3.616

7.  Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice.

Authors:  B S Graham; L A Bunton; P F Wright; D T Karzon
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

Review 8.  Alternative generation of MHC class II-restricted epitopes: not so exceptional?

Authors:  Laurence C Eisenlohr
Journal:  Mol Immunol       Date:  2012-11-30       Impact factor: 4.407

9.  Exogenous, TAP-independent lysosomal presentation of a respiratory syncytial virus CTL epitope.

Authors:  Carolina Johnstone; Manuel Ramos; Blanca García-Barreno; Daniel López; José A Melero; Margarita Del Val
Journal:  Immunol Cell Biol       Date:  2012-08-28       Impact factor: 5.126

10.  Identification of immunodominant epitopes derived from the respiratory syncytial virus fusion protein that are recognized by human CD4 T cells.

Authors:  Grada M van Bleek; Martien C Poelen; Robbert van der Most; Humphrey F Brugghe; Hans A M Timmermans; Claire J Boog; Peter Hoogerhout; Henny G Otten; Cécile A C M van Els
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

View more
  4 in total

1.  Anti-COVID-19 multi-epitope vaccine designs employing global viral genome sequences.

Authors:  Tahreem Zaheer; Maaz Waseem; Walifa Waqar; Hamza Arshad Dar; Muhammad Shehroz; Kanwal Naz; Zaara Ishaq; Tahir Ahmad; Nimat Ullah; Syeda Marriam Bakhtiar; Syed Aun Muhammad; Amjad Ali
Journal:  PeerJ       Date:  2020-08-03       Impact factor: 2.984

2.  Immunoproteomic analysis of a Chikungunya poxvirus-based vaccine reveals high HLA class II immunoprevalence.

Authors:  Elena Lorente; Alejandro Barriga; Eilon Barnea; Concepción Palomo; Juan García-Arriaza; Carmen Mir; Mariano Esteban; Arie Admon; Daniel López
Journal:  PLoS Negl Trop Dis       Date:  2019-07-05

3.  Epitope-specific airway-resident CD4+ T cell dynamics during experimental human RSV infection.

Authors:  Aleks Guvenel; Agnieszka Jozwik; Stephanie Ascough; Seng Kuong Ung; Suzanna Paterson; Mohini Kalyan; Zoe Gardener; Emma Bergstrom; Satwik Kar; Maximillian S Habibi; Allan Paras; Jie Zhu; Mirae Park; Jaideep Dhariwal; Mark Almond; Ernie Hc Wong; Annemarie Sykes; Jerico Del Rosario; Maria-Belen Trujillo-Torralbo; Patrick Mallia; John Sidney; Bjoern Peters; Onn Min Kon; Alessandro Sette; Sebastian L Johnston; Peter J Openshaw; Christopher Chiu
Journal:  J Clin Invest       Date:  2020-01-02       Impact factor: 14.808

4.  Immunoinformatic identification of B cell and T cell epitopes in the SARS-CoV-2 proteome.

Authors:  Stephen N Crooke; Inna G Ovsyannikova; Richard B Kennedy; Gregory A Poland
Journal:  Sci Rep       Date:  2020-08-25       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.